PFE vs. SPGP
Compare and contrast key facts about Pfizer Inc. (PFE) and Invesco S&P 500 GARP ETF (SPGP).
SPGP is a passively managed fund by Invesco that tracks the performance of the S&P 500 GARP Index. It was launched on Jun 16, 2011.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PFE or SPGP.
Performance
PFE vs. SPGP - Performance Comparison
Returns By Period
In the year-to-date period, PFE achieves a -8.59% return, which is significantly lower than SPGP's 12.12% return. Over the past 10 years, PFE has underperformed SPGP with an annualized return of 2.42%, while SPGP has yielded a comparatively higher 14.00% annualized return.
PFE
-8.59%
-15.12%
-10.82%
-11.60%
-2.75%
2.42%
SPGP
12.12%
1.90%
4.71%
19.93%
13.56%
14.00%
Key characteristics
PFE | SPGP | |
---|---|---|
Sharpe Ratio | -0.52 | 1.28 |
Sortino Ratio | -0.61 | 1.83 |
Omega Ratio | 0.93 | 1.23 |
Calmar Ratio | -0.23 | 1.98 |
Martin Ratio | -1.58 | 5.97 |
Ulcer Index | 8.11% | 3.17% |
Daily Std Dev | 24.50% | 14.78% |
Max Drawdown | -54.82% | -42.08% |
Current Drawdown | -53.63% | -1.95% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between PFE and SPGP is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Risk-Adjusted Performance
PFE vs. SPGP - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Pfizer Inc. (PFE) and Invesco S&P 500 GARP ETF (SPGP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PFE vs. SPGP - Dividend Comparison
PFE's dividend yield for the trailing twelve months is around 6.77%, more than SPGP's 1.33% yield.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer Inc. | 6.77% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.54% | 3.70% | 3.48% | 3.34% | 3.14% |
Invesco S&P 500 GARP ETF | 1.33% | 1.24% | 1.22% | 0.69% | 1.10% | 0.86% | 0.95% | 0.68% | 0.89% | 1.12% | 1.52% | 2.11% |
Drawdowns
PFE vs. SPGP - Drawdown Comparison
The maximum PFE drawdown since its inception was -54.82%, which is greater than SPGP's maximum drawdown of -42.08%. Use the drawdown chart below to compare losses from any high point for PFE and SPGP. For additional features, visit the drawdowns tool.
Volatility
PFE vs. SPGP - Volatility Comparison
Pfizer Inc. (PFE) has a higher volatility of 6.71% compared to Invesco S&P 500 GARP ETF (SPGP) at 5.14%. This indicates that PFE's price experiences larger fluctuations and is considered to be riskier than SPGP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.